sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Emerging Growth Conference
Jaguar Health, Inc. (NASDAQ:JAGX) announced that its founder, president, and CEO, Lisa Conte, will deliver a virtual presentation at the Emerging Growth Conference on June 18, 2025. The event will focus on updates and near-term catalysts for the company.
This conference presentation will be available online from 9:40 to 10:10 AM Eastern Time, with a replay accessible on EmergingGrowth.com and the Emerging Growth YouTube Channel. Jaguar Health, a pharmaceutical company, emphasizes developing plant-based proprietary medicines targeting gastrointestinal distress for humans and animals.
Napo Pharmaceuticals, a Jaguar subsidiary, offers crofelemer for noninfectious diarrhea in adults with HIV/AIDS. Meanwhile, Napo Therapeutics, established in Milan, works to expand crofelemer's reach in Europe. Magdalena Biosciences, a joint venture with Filament Health Corp., aims to develop plant-derived medicines for mental health.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.